EN
FR AR

Press releases

March 24, 2026

Koios Medical SmartUltrasoundTM Joins HCK's TEO MultiLink Network Expanding the Reach of AI-Powered Ultrasound Diagnostics, Enriching the Offering for Partners & Customers

Hckonnect

Geneva, Switzerland – March 24, 2026 – Koios Medical, Inc. and Healthcare Konnect (HCK) announced that Koios Medical has joined TEO MultiLink, HCK's collaboration hub connecting AI companies to cross-sell and co-distribute their solutions through a shared network of over 3,500 healthcare organizations worldwide. Over just the past few months, companies participating in the MultiLink Network have experienced growing momentum and engagement from healthcare institutions across Germany, Belgium, France, Portugal, South America, North Africa, and the Middle East.

Koios Medical is U.S.-based, specializing in AI-powered clinical decision support (DS) for ultrasound imaging used for cancer detection and diagnosis. Its Koios DS platform uses proprietary algorithms trained on over 3 million ultrasound images to provide real-time cancer risk assessments and workflow automation and reporting for breast and thyroid examinations. The software classifies suspicious lesions, aligns findings to ACR BI-RADS and TI-RADS categories, and automatically prepopulates diagnostic reports. Koios DS holds multiple FDA 510(k) clearances and CE marking and is currently deployed across more than 2,000 clinical sites in 34 countries. Published data indicates a 35–40% reduction in benign tissue biopsies and a 40% reduction in unnecessary follow-up appointments all while improving cancer detection rates from 6-10% when the software is used in clinical practice. The software is also embedded within both GE Healthcare LOGIQ and Philips Ultrasound EPIC and Affiniti ultrasound scanner hardware.  

Through participation in TEO MultiLink, Koios Medical (Koios) will now be actively promoted by a growing ecosystem of complementary AI solution providers reciprocally cross-selling one anothers’  solutions. Using HCK’s MultiLink technology, Koios can establish a curated platform of complimentary, proven and trusted partner offerings and deliver these solutions directly to its installed customer base. For healthcare institutions, this collaboration framework means a single integration point can access a broader range of validated AI tools without multiplying vendor relationships, technical setups, or maintenance workflows. Institutions connect once and activate multiple solutions as needed through their one trusted provider relationship.

"We understand the challenges facing our customers struggling to keep up with the rising demand for AI solutions, but are often overwhelmed by the plethora of AI solutions coming to market. In working with TEO Multilink, we can offer a “best of breed” approach within a simplified deployment model from a curated portfolio of proven solutions. We take pride in being a part of this community of solutions and look forward to supporting our TEO Multilink partners and their clinical customers. " says Chad McClennan, President & CEO at Koios Medical.

"We are pleased to welcome Koios Medical into the TEO MultiLink network. Their expertise in AI-powered ultrasound diagnostics for breast and thyroid cancer strengthens the range of AI solutions accessible to healthcare institutions through our platform. This is what MultiLink was built for: enabling AI companies to amplify each other's reach, while providing institutions the benefit of easy access to  a comprehensive set of interoperable solutions," says Marwan Senhaji, CEO of Healthcare Konnect (HCK).

About Koios Medical
Koios Medical is the leader in AI-driven clinical decision support, developing Smart Ultrasound™ software that harnesses advanced artificial intelligence and machine learning to assist radiologists in the early detection and accurate diagnosis of breast and thyroid cancers. Koios DS™ Breast is the only FDA-cleared AI cancer diagnosis software for breast ultrasound images, acting as an expert on-demand second opinion for classifying suspicious breast lesions and thyroid nodules. Reimbursement-eligible in the US, the CE Marked platform integrates directly on ultrasound scanners or any PACS system, proven to improve diagnostic accuracy, reduce unnecessary biopsies and follow-ups, streamline workflows, enhance patient outcomes, and lower overall healthcare costs. For more information, visit www.koiosmedical.com.

koiosmedical.com
info@koiosmedical.com

About Healthcare Konnect (HCK)
Healthcare Konnect is a leading Swiss platform that specializes in the evaluation, integration, deployment and monitoring of AI-based softwares as medical devices. HCK is committed to connecting healthcare professionals with cutting-edge medical technologies to improve patient care and outcomes.

www.hckonnect.com
info@hckonnect.com

MEDIA CONTACT
Marwan SENHAJI
CEO
HCK HealthCare Konnect
msenhaji@hckonnect.com
+41 79 640 29 13

Tanya Haugh
Social Media Owl
Koios Medical, Inc.
thaugh@koiosmedical.com

Latest articles

View All Articles
Hckonnect

March 26, 2026

AZmed Joins HCK's TEO MultiLink Network to Expand the Reach of AI-Powered Radiology and Enrich their Offer with New AI Solutions from the Network

Press releases

Hckonnect

January 21, 2026

Healthcare Konnect (HCK) and CIMC partner to deploy and evaluate innovative imaging solutions in routine clinical practice

Press releases

Hckonnect

January 06, 2026

2025: The year AI in healthcare shifted from experimental to operational.

News